Causal Inference and Estimands in Clinical Trials

References

• Aalen, O. O., Cook, R., and Røysland, K. (2015), “Does Cox Analysis of a Randomized Survival Study Yield a Causal Treatment Effect?,” Lifetime Data Analysis, 21, 579–593. DOI: 10.1007/s10985-015-9335-y.
   PubMed Web of Science ®Google Scholar
• Andersen, P. K., Syriopoulou, E., and Parner, E. T. (2017), “Causal Inference in Survival Analysis Using Pseudo-Observations,” Statistics in Medicine, 36, 2669–2681. DOI: 10.1002/sim.7297.
   PubMed Web of Science ®Google Scholar
• Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996), “Identification of Causal Effects Using Instrumental Variables,” Journal of the American Statistical Association, 91, 444–455. DOI: 10.1080/01621459.1996.10476902.
   Web of Science ®Google Scholar
• Austin, P. C. (2008), “A Critical Appraisal of Propensity Score Matching in the Medical Literature from 1996 to 2003,” Statistics in Medicine, 27, 2037–2049. DOI: 10.1002/sim.3150.
   PubMed Web of Science ®Google Scholar
• Billingham, L. J., and Abrams, K. R. (2002), “Simultaneous Analysis of Quality of Life and Survival Data,” Statistical Methods in Medical Research, 11, 25–48. DOI: 10.1191/0962280202sm269ra.
   PubMed Web of Science ®Google Scholar
• Bornkamp, B., and Bermann, G. (2019), “Estimating the Treatment Effect in a Subgroup Defined by an Early Post-Baseline Biomarker Measurement in Randomized Clinical Trials With Time-to-event Endpoint,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2019.1575280.
   Web of Science ®Google Scholar
• Carpenter, J. R., Roger, J. H., and Kenward, M. G. (2013), “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics, 23, 1352–1371. DOI: 10.1080/10543406.2013.834911.
   PubMed Web of Science ®Google Scholar
• D’Agostino, R. B. (1998), “Tutorial in Biostatistics: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non-Randomized Control Group,” Statistics in Medicine, 17, 2265–2281. DOI: 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.
   PubMed Web of Science ®Google Scholar
• Daniel, R. M., Cousens, S. N., De Stavola, B. L., Kenward, M. G., and Sterne, J. A. (2013), “Methods for Dealing With Time-Dependent Confounding,” Statistics in Medicine, 32, 1584–1618. DOI: 10.1002/sim.5686.
   PubMed Web of Science ®Google Scholar
• Dawid, A. P. (2000), “Causal Inference Without Counterfactuals (with discussion),” Journal of the American Statistical Association, 95, 407–424. DOI: 10.1080/01621459.2000.10474210.
   Web of Science ®Google Scholar
• Ding, P., and Lu, J. (2017), “Principal Stratification Analysis Using Principal Scores,” Journal of the Royal Statistical Society, Series B, 79, 757–777. DOI: 10.1111/rssb.12191.
   Google Scholar
• ICH Harmonised Guideline E9(R1) (2017), “Estimands and Sensitivity Analysis in Clinical Trials” (Step 1 version dated 16 June 2017).
   Google Scholar
• Imbens, G. W., and Rubin, D. B. (1997), “Bayesian Inference for Causal Effects in Randomized Experiments With Noncompliance,” The Annals of Statistics, 25, 305–327. DOI: 10.1214/aos/1034276631.
   Web of Science ®Google Scholar
• Frangakis, C. E., and Rubin, D. B. (2002), “Principal Stratification in Causal Inference,” Biometrics, 58, 21–29. DOI: 10.1111/j.0006-341X.2002.00021.x.
   PubMed Web of Science ®Google Scholar
• Gail, M. H., Wieand, S., and Piantadosi, S. (1984), “Biased Estimates of Treatment Effect in Randomized Experiments With Nonlinear Regressions and Omitted Covariates,” Biometrika, 71, 431–444. DOI: 10.1093/biomet/71.3.431.
   Web of Science ®Google Scholar
• Greenland, S., Pearl, J., and Robins, J. M. (1999), “Causal Diagrams for Epidemiological Research,” Epidemiology, 10, 37–48. DOI: 10.1097/00001648-199901000-00008.
   PubMed Web of Science ®Google Scholar
• Hayden, D., Pauler, D. K., and Schoenfeld, D. (2005), “An Estimator for Treatment Comparisons among Survivors in Randomized Trials,” Biometrics, 61, 305–310. DOI: 10.1111/j.0006-341X.2005.030227.x.
   PubMed Web of Science ®Google Scholar
• Hernán, M. A., and Scharfstein, D. (2018), “Cautions as Regulators Move to End Exclusive Reliance on Intention to Treat,” Annals of Internal Medicine, 168, 515–516. DOI: 10.7326/M17-3354.
   PubMed Web of Science ®Google Scholar
• Jo, B., and Stuart, E. A. (2009), “On the Use of Propensity Scores in Principal Causal Effect Estimation,” Statistics in Medicine, 28, 2857–2875. DOI: 10.1002/sim.3669.
   PubMed Web of Science ®Google Scholar
• Johnson, B. A., and Tsiatis, A. A. (2004), “Estimating Mean Response as a Function of Treatment Duration in an Observational Study, Where Duration May Be Informatively Censored,” Biometrics, 60, 315–323. DOI: 10.1111/j.0006-341X.2004.00175.x.
   PubMed Web of Science ®Google Scholar
• Johnson, B. A., and Tsiatis, A. A. (2005), “Semiparametric Inference in Observational Duration-Response Studies, with Duration Possibly Right-Censored,” Biometrika, 92, 605–618.
   Web of Science ®Google Scholar
• Kosuke, I. (2008), “Sharp Bounds on the Causal Effects in Randomized Experiments with ‘Truncation-by-Death ‘,” Statistics & Probability Letters, 78, 144–149.
   Web of Science ®Google Scholar
• Lachin, J. M. (1999), “Worst-Rank Score Analysis With Informatively Missing Observations in Clinical Trials,” Controlled Clinical Trials, 20, 408–422. DOI: 10.1016/S0197-2456(99)00022-7.
   PubMedGoogle Scholar
• Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., and Hsiao, J. K. (2005), “Effectiveness of Antipsychotic Drugs in Patients With Chronic Schozophrenia,” New England Journal of Medicine, 353, 1209–1223. DOI: 10.1056/NEJMoa051688.
   PubMed Web of Science ®Google Scholar
• Little, R., and Kang, S. (2015), “Intention-To-Treat Analysis With Treatment Discontinuation and Missing Data in Clinical Trials,” Statistics in Medicine, 34, 2381–2390. DOI: 10.1002/sim.6352.
   PubMed Web of Science ®Google Scholar
• Little, R. J., and Rubin, D. B. (2000), “Causal Effects in Clinical and Epidemiological Studies via Potential Outcomes,” Annual Review of Public Health, 21, 121–145. DOI: 10.1146/annurev.publhealth.21.1.121.
   PubMed Web of Science ®Google Scholar
• Lou, Y., Jones, M. P., and Sun, W. (2019), “Estimation of Causal Effects in Clinical Endpoint Bioequivalence Studies in the Presence of Intercurrent Events: Noncompliance and Missing Data,” Journal of Biopharmaceutical Statistics, 29, 151–173. DOI: 10.1080/10543406.2018.1489408.
   PubMed Web of Science ®Google Scholar
• Lu, X., Mehrotra, D. V., and Shepherd, B. E. (2013), “Rank-Based Principal Stratum Sensitivity Analyses,” Statistics in Medicine, 2, 4526–4539. DOI: 10.1002/sim.5849.
   Google Scholar
• Lunceford, J. K., and Davidian, M. (2004), “Stratification and Weighting via the Propensity Score in Estimation of Causal Treatment Effects: A Comparative Study,” Statistics in Medicine, 23, 2937–2960. DOI: 10.1002/sim.1903.
   PubMed Web of Science ®Google Scholar
• Magnusson, B. P., Schmidli, H., Rouyrre, N., and Scharfstein, D. O. (2019), “Bayesian Inference for a Principal Stratum Estimand to Assess the Treatment Effect in a Subgroup Characterized By Post-Randomization Events,” Statistics in Medicine, 38, 4761–4771. DOI: 10.1002/sim.8333.
   PubMed Web of Science ®Google Scholar
• Mallinckrodt, C., Molenberghs, G., and Rathmann, S. (2017), “Choosing Estimands in Clinical Trials With Missing Data,” Pharmaceutical Statistics, 16, 29–36. DOI: 10.1002/pst.1765.
   PubMed Web of Science ®Google Scholar
• Miratrix, L., Furey, J., Feller, A., Grindal, T., and Page, L. C. (2018), “Bounding, an Accessible Method for Estimating Principal Causal Effects, Examined and Explained,” Journal of Research on Educational Effectiveness, 11, 133–162. DOI: 10.1080/19345747.2017.1379576.
   Web of Science ®Google Scholar
• Mehrotra, D., Li, X., and Gilbert, P. (2006), “A Comparison of Eight Methods for the Dual-Endpoint Evaluation of Efficacy in a Proof-of-Concept HIV Vaccine Trial,” Biometrics, 62, 893–900. DOI: 10.1111/j.1541-0420.2005.00516.x.
   PubMed Web of Science ®Google Scholar
• Mehrotra, D. V., Liu, F., and Permutt, T. (2017), “Missing Data in Clinical Trials: Control-Based Mean Imputation and Sensitivity Analysis,” Pharmaceutical Statistics, 16, 378–392. DOI: 10.1002/pst.1817.
   PubMed Web of Science ®Google Scholar
• Moodie, E. E. M., Richardson, T. S., and Stephens, D. A. (2007), “Demystifying Optimal Dynamic Treatment Regimes,” Biometrics, 63, 447–455. DOI: 10.1111/j.1541-0420.2006.00686.x.
   PubMed Web of Science ®Google Scholar
• Murphy, S. A. (2003), “Optimal Dynamic Treatment Regimes” (with discussion), Journal of the Royal Statistical Society, Series B, 65, 331–366. DOI: 10.1111/1467-9868.00389.
   Google Scholar
• Murphy, S. A. (2005), “An Experimental Design for the Development of Adaptive Treatment Strategies,” Statistics in Medicine, 24, 1455–1481.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC) (2010), “The Prevention and Treatment of Missing Data in Clinical Trials,” in Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioral and Social Sciences and Education, Washington, DC: The National Academies Press.
   Google Scholar
• Neyman, J. (1923), “On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9,” Statistical Science, 5, 465–480.
   Google Scholar
• Pearl, J. (2001), “Causal Inference in the Health Sciences: A Conceptual Introduction,” Health Services and Outcomes Research Methodology, 2, 189–220. DOI: 10.1023/A:1020315127304.
   Google Scholar
• Pearl, J. (2009), “Causal Inference in Statistics: An Overview,” Statistics Surveys, 3, 96–146.
   Google Scholar
• Permutt, T. (2016a), “A Taxonomy of Estimands for Regulatory Clinical Trials With Discontinuations,” Statistics in Medicine, 35, 2865–2875. DOI: 10.1002/sim.6841.
   PubMed Web of Science ®Google Scholar
• Permutt, T. (2016b), “Sensitivity Analysis for Missing Data in Regulatory Submissions,” Statistics in Medicine, 35, 2876–2879.
   PubMed Web of Science ®Google Scholar
• Permutt, T. (2018), “Effects in Adherent Subjects,” Statistics in Biopharmaceutical Research, 10, 233–235.
   Web of Science ®Google Scholar
• Permutt, T. 2019), “Treatment Effects, Comparisons, and Randomization,” Statistics in Biopharmaceutical Research,5.2019.1624192. DOI: 10.1080/1946631.
   Web of Science ®Google Scholar
• Permutt, T., and Li, F. (2017), “Trimmed Means for Symptom Trials With Dropouts,” Pharmaceutical Statistics, 16, 20–28. DOI: 10.1002/pst.1768.
   PubMed Web of Science ®Google Scholar
• Qu, Y., Fu, H., Luo, J., and Ruberg, S. J. (2019), “A General Framework for Treatment Effect Estimators Considering Patient Adherence,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2019.1700157.
   Google Scholar
• Ratitch, B., Bell, J., Mallinckrodt, C., Bartlett, J. W., Goel, N., Molenberghs, G., O’Kelly, M., Singh, P., and Lipkovich, I. (2019), “Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice,” Therapeutic Innovation & Regulatory Science, DOI: 10.1177/2168479019838827.
   Google Scholar
• Richardson, T. S., and Robins, J. M. (2013), “Single World Intervention Graphs (SWIGs): A Unification of the Counterfactual and Graphical Approaches to Causality,” Working Paper Number 128, Center for Statistics and the Social Sciences, University of Washington, available at https://www.csss.washington.edu/Papers/wp128.pdf.
   Google Scholar
• Robins, J. M. (1986), “A New Approach to Causal Inference in Mortality Studies With a Sustained Exposure Period—Application to Control of the Healthy Worker Survivor Effect,” Mathematical Modelling, 7, 1393–1512. DOI: 10.1016/0270-0255(86)90088-6.
   Web of Science ®Google Scholar
• Robins, J. M. (1998), “Correction for Non-Compliance in Equivalence Trials,” Statistics in Medicine, 17, 269–302.
   PubMed Web of Science ®Google Scholar
• Robins, J. M., and Hernán, M. A. (2009), “Estimation of the Causal Effects of Time-Varying Exposures,” in Longitudinal Data Analysis, eds. G. Fitzmaurice, M. Davidian, G. Verbeke, and G. Molenberghs, New York: Chapman and Hall/CRC Press, pp. 553–599.
   Google Scholar
• Robins, J. M., Hernán, M. A., and Brumback, B. (2000), “Marginal Structural Models and Causal Inference in Epidemiology,” Epidemiology, 11, 550–560. DOI: 10.1097/00001648-200009000-00011.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. (1978a), “Bayesian Inference for Causal Effects: The Role of Randomization,” The Annals of Statistics, 6, 34–58. DOI: 10.1214/aos/1176344064.
   Web of Science ®Google Scholar
• Rubin, D. B. (1978b), “Multiple Imputations in Sample Surveys—A Phenomenological Bayesian Approach to Nonresponse,” in Imputation and Editing of Faulty or Missing Survey Data, Washington, DC: U.S. Department of Commerce, pp. 1–23.
   Google Scholar
• Rubin, D. B. (1987), Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
   Google Scholar
• Rubin, D. B. (1998), “More Powerful Randomization-Based p-Values in Double-Blind Trials With Noncompliance” (with discussion), Statistics in Medicine, 17, 371–389.
   PubMed Web of Science ®Google Scholar
• Rufibach, K. (2018), “Treatment Effect Quantification for Time-To-Event Endpoints—Estimands, Analysis Strategies, and Beyond,” arXiv no. 1711.07518v4.
   Google Scholar
• Shepherd, B. E., Gilbert, P. B., and Dupont, C. T. (2011), “Sensitivity Analyses Comparing Time-To-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity,” Biometrics, 67, 1100–1110. DOI: 10.1111/j.1541-0420.2010.01508.x.
   PubMed Web of Science ®Google Scholar
• Shortreed, S. M., and Moodie, E. E. M. (2012), “Estimating the Optimal Dynamic Antipsychotic Treatment Regime: Evidence from the Sequential Multiple Assignment Randomized CATIE Schizophrenia Study,” Journal of the Royal Statistical Society, Series C, 61, 577–599. DOI: 10.1111/j.1467-9876.2012.01041.x.
   Web of Science ®Google Scholar
• Stuart, E. A. (2010), “Matching Methods for Causal Inference: A Review and a Look Forward,” Statistical Science, 25, 1–21. DOI: 10.1214/09-STS313.
   PubMed Web of Science ®Google Scholar
• VanderWeele, T. J. (2011), “Principal Stratification—Uses and Limitations,” The International Journal of Biostatistics, 7, 1–14. DOI: 10.2202/1557-4679.1329.
   Google Scholar
• VanderWeele, T. J., and Hernán, M. A. (2013), “Causal Inference Under Multiple Versions of Treatment,” Journal of Causal Inference, 1, 1–20. DOI: 10.1515/jci-2012-0002.
   PubMedGoogle Scholar
• VanderWeele, T. J., and Vansteelandt, S. (2009), “Conceptual Issues Concerning Mediation, Interventions and Composition,” Statistics and Its Interface, 2, 457–468. DOI: 10.4310/SII.2009.v2.n4.a7.
   Web of Science ®Google Scholar
• Wang, D., and Pocock, S. (2016), “A Win Ratio Approach to Comparing Continuous Non-Normal Outcomes in Clinical Trials,” Pharmaceutical Statistics, 15, 238–245. DOI: 10.1002/pst.1743.
   PubMed Web of Science ®Google Scholar
• White, I. R., Joseph, R., and Best, N. A. (2019), “A Causal Modelling Framework for Reference-Based Imputation and Tipping Point Analysis,” Journal of Biopharmaceutical Statistics, DOI: 10.1080/10543406.2019.1684308.
   PubMedGoogle Scholar
• Zhang, J. L., and Rubin, D. B. (2003), “Estimation of Causal Effects via Principal Stratification When Some Outcomes Are Truncated by ‘Death’,” Journal of Educational and Behavioral Statistics, 28, 353–368. DOI: 10.3102/10769986028004353.
   Web of Science ®Google Scholar
• Zheng, D., Chen, Q., Chen, M.-H., and Ibrahim, J. G. (2012), “Estimating Treatment Effects With Treatment Switching via Semicompeting Risks Models: An Application to a Colorectal Cancer Study,” Biometrika, 99, 167–184. DOI: 10.1093/biomet/asr062.
   PubMed Web of Science ®Google Scholar